[1]
2026. PHARMACOECONOMIC IMPACT OF POST–DEEP BRAIN STIMULATION MEDICATION USE AND ADVERSE EVENT PROFILE IN PATIENTS WITH PARKINSON’S DISEASE IN PAKISTAN. Frontier in Medical and Health Research. 4, 6 (Jun. 2026), 320–330.